Research & Implementation Science

Tanzania Health Promotion Support (THPS) in collaboration with Ministry of Health ,Community Development , Gender , Elderly and Children(MOHCDGEC)– National AIDS Control Program (NACP)  , U.S. Centres for Disease Control and Prevention (CDC), United States Agency for International Development (USAID),  United States Department of Defence (DoD), and Population Council  have been awarded funds to conduct a study on the ‘Evaluation of the impact of a community health agent intervention on antiretroviral therapy retention and adherence in Tanzania’

The randomized cluster control study is conducted at 20 health facilities (10 being intervention sites and the other 10 control sites) in three regions of Tanzania namely Mbeya (Mbeya Regional Refferal Hospital ,Mbalizi Ifisi District Hopital, ,Tukuyu District Hospital,Kyela District Hospital and Mbarali  Mission Hopital and Chunya District Hopital) Songwe (Ileje District Hopital and Tunduma health centre, Kagera (Biharamulo District Hospital, Nyakahanga DDH, Kyerwa, Kaigara Health Centre, Ndolage Hospital   and Rubya DDH, and Pwani (Mlandizi, Tumbi, Kisarawe, Mkoani, Mkuranga and Bagamoyo) .

The results of the study will improve understanding of how CBHS providers can contribute to the HIV continuum of care and provide an evidence base to inform the development of government of Tanzania policies and programmatic guidelines surrounding use of CBHS provider’s . The study will also address the following issues on linkage and retention

  • Long waiting hours at the facility (clients will meet at the support group for only 1 hr.)
  • Distance to health facility(CBHS will deliver the drugs to the community)
  • Transport issues (No need for money to and fro the clinic)
  • Improved Disclosure through peer support by CBHS

 Intervention Model consists of:

  • Individualized personal counselling at diagnosis
  • Monthly support group meetings at the community
  • Enhanced group discussion and education
  • ART delivery at monthly community meetings for eligible clients
  • Other drug delivery as deemed appropriate by clinical staff
  • Health screening at community meetings for eligible clients
  • Enhanced tracking through mobile phones and physical visits
  • Improved Disclosure through peer support by CBHS